These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7814866)

  • 1. Selective processing of exogenous antigens by antigen-presenting cells with deleted MHC genes.
    Diment S; Shinde S
    J Immunol; 1995 Jan; 154(2):530-5. PubMed ID: 7814866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extracellular domains of MHC class II molecules determine their processing requirements for antigen presentation.
    Kjer-Nielsen L; Perera JD; Boyd LF; Margulies DH; McCluskey J
    J Immunol; 1990 Apr; 144(8):2915-24. PubMed ID: 1969876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.
    Brooks AG; Campbell PL; Reynolds P; Gautam AM; McCluskey J
    J Immunol; 1994 Dec; 153(12):5382-92. PubMed ID: 7989744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.
    Riberdy JM; Cresswell P
    J Immunol; 1992 Apr; 148(8):2586-90. PubMed ID: 1373173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of endogenously synthesized hen egg-white lysozyme retained in the endoplasmic reticulum or in secretory form gives rise to a similar but not identical set of epitopes recognized by class II-restricted T cells.
    Adorini L; Guéry JC; Fuchs S; Ortiz-Navarrete V; Hämmerling GJ; Momburg F
    J Immunol; 1993 Oct; 151(7):3576-86. PubMed ID: 7690807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenous antigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells.
    Brooks AG; McCluskey J
    J Immunol; 1993 May; 150(9):3690-7. PubMed ID: 8473726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain.
    Nadimi F; Moreno J; Momburg F; Heuser A; Fuchs S; Adorini L; Hämmerling GJ
    Eur J Immunol; 1991 May; 21(5):1255-63. PubMed ID: 2037011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
    Matousek MP; Nedrud JG; Harding CV
    J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of fibroblasts with a unique defect in processing antigens with disulfide bonds.
    Merkel BJ; Mandel R; Ryser HJ; McCoy KL
    J Immunol; 1995 Jan; 154(1):128-36. PubMed ID: 7995932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitopic analysis by anti-I-Ak monoclonal antibodies of I-Ak-restricted presentation of lysozyme peptides.
    Rosloniec EF; Gay D; Freed JH
    J Immunol; 1989 Jun; 142(12):4176-83. PubMed ID: 2470818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
    Svensson M; Stockinger B; Wick MJ
    J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of antigens internalized through the B cell receptor requires newly synthesized MHC class II molecules.
    Forquet F; Barois N; Machy P; Trucy J; Zimmermann VS; Leserman L; Davoust J
    J Immunol; 1999 Mar; 162(6):3408-16. PubMed ID: 10092796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different roles for thiol and aspartyl proteases in antigen presentation of ovalbumin.
    Diment S
    J Immunol; 1990 Jul; 145(2):417-22. PubMed ID: 1694878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ek beta mutant antigen-presenting cell lines expressing altered Ak alpha molecules.
    Quill H; Schwartz RH; Glimcher LH
    J Immunol; 1986 May; 136(9):3351-9. PubMed ID: 3082986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation on class II MHC molecules of endogenous lysozyme targeted to the endocytic pathway.
    Parra-López CA; Lindner R; Vidavsky I; Gross M; Unanue ER
    J Immunol; 1997 Mar; 158(6):2670-9. PubMed ID: 9058800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.